Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
376,96 B | 2,49% | 4/6 | 25,40% | -37,26% | 17,30% | DOWN |
|
Amgen NasdaqGS:AMGN |
188,14 B | 7,37% | 3/6 | 2,72% | -8,34% | 0,29% | UP |
|
Gilead Sciences NasdaqGS:GILD |
169,23 B | 3,30% | 5/6 | 4,53% | -58,34% | 17,35% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
41,90 B | 46,06% | 4/6 | 49,91% | 0,61% | 42,42% | DOWN |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Biogen NasdaqGS:BIIB |
27,53 B | -10,57% | 1/6 | -1,25% | 4,97% | 10,09% | UP |
|
Incyte NasdaqGS:INCY |
17,98 B | 41,79% | 5/6 | 8,74% | 28,31% | 17,90% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,54 B | 12,22% | 5/6 | 45,50% | 58,53% | 71,56% | DOWN |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
8,07 B | 48,13% | 5/6 | -45,97% | 17,85% | 38,84% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,53 B | 19,97% | 5/6 | 59,76% | -49,02% | 0,49% | UP |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,59 B | 29,02% | 5/6 | 15,27% | -27,83% | 54,25% | DOWN |
|
Viking Therapeutics NasdaqCM:VKTX |
3,46 B | 0,00% | 0/4 | 0,00% | 0,00% | 232,55% | DOWN |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
2,90 B | 40,93% | 5/6 | 5,58% | 23,75% | 47,18% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
2,55 B | 10,07% | 5/6 | 42,67% | -49,99% | 51,84% | UP |
|
BioCryst Pharmaceuticals NasdaqGS:BCRX |
2,38 B | 110,83% | 5/6 | -11,42% | 27,15% | 111,19% | UP |
